Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Medical Care Cost of Oropharyngeal Cancer among Texas Patients

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d7651497e161">Background</h5> <p id="P1">The incidence of oropharyngeal cancer (OPC) is rising rapidly, with the majority of cases being attributable to human papillomavirus (HPV). Despite the availability of a vaccine, rates of HPV vaccination among Texas youth are low. The healthcare cost of OPC in Texas is unknown. The aims of this study were to estimate the first two years cost of treating new cases of OPC and determine the predictors of OPC treatment cost in Texas. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d7651497e166">Methods</h5> <p id="P2">This study included a retrospective cohort of 467 Texas patients with commercial insurance claims data with OPC diagnosed from 2011 to 2014 and a control group of 467 non-cancer patients obtained with propensity score matching. Total health care cost during the first two years after the index date was measured. A generalized linear model was used to identify predictors of monthly cost during the two years after the index date. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d7651497e171">Results</h5> <p id="P3">The mean differential adjusted health care cost for OPC cases was $139,749 in the first two years. The mean adjusted monthly cost in the first two years was $6,693 for cases and $840 for controls. Age, comorbidity, mental health, pre-diagnostic health care cost, and time index were significant predictors of monthly cost. </p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d7651497e176">Conclusions</h5> <p id="P4">Medical care cost was about $140,000 in the first two years after diagnosis of OPC among commercially insured patients in Texas. </p> </div><div class="section"> <a class="named-anchor" id="S5"> <!-- named anchor --> </a> <h5 class="section-title" id="d7651497e181">Impact</h5> <p id="P5">The cost estimates provide important parameters for development of decision-analytic models to inform decision-makers about the potential value of initiatives for increasing the HPV immunization rate in the State. </p> </div>

          Related collections

          Author and article information

          Journal
          Cancer Epidemiology Biomarkers & Prevention
          Cancer Epidemiol Biomarkers Prev
          American Association for Cancer Research (AACR)
          1055-9965
          1538-7755
          August 31 2017
          September 2017
          September 2017
          August 24 2017
          : 26
          : 9
          : 1443-1449
          Article
          10.1158/1055-9965.EPI-17-0220
          5903433
          28838945
          fec1fd7f-34ae-4f4b-b3d6-9ed6c764c2b3
          © 2017
          History

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content5,269

          Cited by17